The Global Sample Preparation Market: growing demand for food analysis due to safety concerns, and increasing adoption of modern extraction techniques across the world are anticipated to propel the growth of the sample preparation market

Published Date: 10/05/2021

The Global Sample Preparation Market is projected to reach USD 9.87 million by 2027 from USD 6.60 million in 2020, at a CAGR of 5.2 %.

Sample preparation remains one of the most significant challenges and bottlenecks in research, but it is crucial to the success of downstream applications. The sample quality that emerges from preparation tasks, like nucleic acid or protein isolation, as well as purification, pipetting, and other liquid-handling requirements, can significantly impact the accuracy of research.

If not performed properly, they can impair entire projects and cost laboratories thousands of dollars in having to duplicate work, yet waste precious samples that cannot be restored. Given the higher scrutiny on research data accuracy, stricter quality standards in applied markets, like clinical testing, forensics, and food and beverage testing, and a greater focus on laboratory efficiency, the labs continue to move toward automated sample preparation methods.

In response, instruments for automated nucleic acid purification and isolation (NAPI), liquid handling, and library preparation for next-generation sequencing (NGS) are gaining popularity. In addition to delivering higher-quality prepared samples, advantages of these systems over manual tasks include the reduction of human error, the significantly less hands-on time required, speed, increased throughput, reproducibility, reliability, and increased laboratory efficiency.

Pharmaceutical products and biological materials are very complex. Although pharmaceutical analyses have been carried out using various highly efficient analytical instruments, a sample preparation procedure is usually necessary to extract and isolate the analytes of interest from these complex matrixes because most analytical instruments cannot handle the matrix directly. The development of sample preparation plays a very important role in pharmaceutical analysis, and its final aim should be to isolate and to purify the analyte from those matrixes.

As important as sample preparation is for pharmaceutical research, the demand for it is expected to increase with increased pharmaceutical funding. The global pharmaceutical industry investment in research and development has increased over the years, from USD 108.1 billion in 2006 to USD 156.7 billion in 2016, as per a 2017 report by the Association of the British Pharmaceutical Industry. For instance, Pfizer increased its research and development expenditure over the years from 7,683 USD million to 8,650 USD million, as per its 2019 annual report.

Hence, with the increasing expenditure in R&D, this market in the pharmaceutical industry is expected to attain good growth over the forecast period.
Increase of income levels in emerging markets such as India and China is leading to a rise in health care spending. Moreover, changing lifestyles and increasing urbanization in these countries have led to a gradual escalation in the incidence of life style related diseases such as cancer, diabetes, and heart disease. This has opened up multiple avenues for expansion in the bio-pharmaceutical sector to conduct research and allocate substantial budget for the same.

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), and others Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Hamilton Company (U.S.), Sigma-Aldrich Corporation (U.S.), NorgenBiotek Corporation (Canada), Millipore Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Roche Applied Science (Switzerland), Illumina, Inc. (U.S.), and Tecan Group Ltd. (Switzerland) are the leading players in the market.

North America dominated the overall sample preparation market, with the United States being the major contributor to the market. The United States is the largest market for biopharmaceuticals, accounting for around a third of the global market, and is the world leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), US firms conduct over half of the world's R&D in pharmaceuticals and hold the intellectual property rights on most new medicines. The increasing number of pharmaceutical companies is driving the growth of the sample preparation market, in the United States. Thus, the market is experiencing stable growth in the region and may flourish in the future.